New Zealand markets closed

ZIVO Bioscience, Inc. (ZIVO)

OTC Markets OTCQB - OTC Markets OTCQB Delayed price. Currency in USD
Add to watchlist
7.90-0.10 (-1.25%)
At close: 02:21PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 25.90M
Enterprise value 26.54M
Trailing P/E N/A
Forward P/E N/A
PEG ratio (5-yr expected) N/A
Price/sales (ttm)247.41
Price/book (mrq)21.13
Enterprise value/revenue 418.86
Enterprise value/EBITDA -3.01

Trading information

Stock price history

Beta (5Y monthly) 0.22
52-week change 3-43.97%
S&P500 52-week change 324.96%
52-week high 317.82
52-week low 30.48
50-day moving average 37.83
200-day moving average 36.12

Share statistics

Avg vol (3-month) 3769
Avg vol (10-day) 31.07k
Shares outstanding 53.28M
Implied shares outstanding 63.28M
Float 81.49M
% held by insiders 156.02%
% held by institutions 10.08%
Shares short (31 Oct 2023) 435.47k
Short ratio (31 Oct 2023) 46.65
Short % of float (31 Oct 2023) 42.61%
Short % of shares outstanding (31 Oct 2023) 42.04%
Shares short (prior month 29 Sept 2023) 412.81k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 327 Oct 2023

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 0.00%
Operating margin (ttm)-3,571.78%

Management effectiveness

Return on assets (ttm)-422.29%
Return on equity (ttm)N/A

Income statement

Revenue (ttm)63.37k
Revenue per share (ttm)0.03
Quarterly revenue growth (yoy)N/A
Gross profit (ttm)N/A
EBITDA N/A
Net income avi to common (ttm)-7.08M
Diluted EPS (ttm)-3.81
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)138.64k
Total cash per share (mrq)0.05
Total debt (mrq)779.09k
Total debt/equity (mrq)N/A
Current ratio (mrq)0.23
Book value per share (mrq)-0.81

Cash flow statement

Operating cash flow (ttm)-5.37M
Levered free cash flow (ttm)-2.69M